Ananym Capital Management proposes cost cuts and potential sale of assets to boost Henry Schein's profits.

Ananym Capital Management, an activist firm, has proposed strategies to boost Henry Schein's profits, including a board refresh, cost cuts, and possibly selling its medical distribution business. Ananym argues that better cost control could unlock up to $300 million in savings, potentially increasing earnings per share by over 35%. The firm also suggests enhancing the company's cash flow to buy more shares.

November 23, 2024
4 Articles